Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001269314 | SCV001448665 | benign | Phenylketonuria | 2020-09-12 | reviewed by expert panel | curation | The c.509+101A>C variant in PAH has a MAF of 0.2325 in the gnomAD European (Non-Finnish) population. This intronic variant does not have a predicted impact on splicing. In summary this variant meets criteria to be classified as benign. PAH-specific ACMG/AMP criteria applied: BA1, BP7 |
Pars Genome Lab | RCV001269314 | SCV001750009 | benign | Phenylketonuria | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001673041 | SCV001885528 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001673041 | SCV005235503 | benign | not provided | criteria provided, single submitter | not provided |